Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · IEX Real-Time Price · USD
32.04
-0.62 (-1.90%)
At close: Jul 19, 2024, 4:00 PM
32.09
+0.05 (0.16%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
HRMY Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for HRMY stock have an average target of 41.67, with a low estimate of 27 and a high estimate of 59. The average target predicts an increase of 30.06% from the current stock price of 32.04.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HRMY stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +62.30% | Jun 25, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +62.30% | Jun 24, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +49.81% | Jun 21, 2024 |
| Needham | Needham | Strong Buy Maintains $50 → $52 | Strong Buy | Maintains | $50 → $52 | +62.30% | May 1, 2024 |
| Needham | Needham | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +56.05% | Apr 30, 2024 |
Financial Forecast
Revenue This Year
724.01M
from 582.02M
Increased by 24.40%
Revenue Next Year
856.08M
from 724.01M
Increased by 18.24%
EPS This Year
2.27
from 2.13
Increased by 6.58%
EPS Next Year
3.97
from 2.27
Increased by 75.08%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 754.3M | 928.3M | 1.2B | 1.6B | 2.4B |
| Avg | 724.0M | 856.1M | 1.0B | 1.2B | 1.8B |
| Low | 688.0M | 773.0M | 829.8M | 980.2M | 1.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 29.6% | 28.2% | 38.8% | 54.3% | 91.5% |
| Avg | 24.4% | 18.2% | 18.0% | 22.8% | 47.6% |
| Low | 18.2% | 6.8% | -3.1% | -3.0% | 4.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 3.17 | 4.42 | 6.30 | 10.43 |
| Avg | 2.27 | 3.97 | 5.22 | 10.13 |
| Low | 1.42 | 3.40 | 4.20 | 9.73 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 48.9% | 94.7% | 58.5% | 99.7% |
| Avg | 6.6% | 75.1% | 31.3% | 94.0% |
| Low | -33.3% | 49.8% | 5.8% | 86.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.